Bumper Offer - Urjas oil Just @ Rs. 1
Zimigut 200 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Hepatic Encephalopathy. The alternative uses of Zimigut 200 Tablet have also been explained below.
The right dosage of Zimigut 200 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Zimigut 200 Tablet also has some side effects, the most common being Flatulence, Bloating or fullness, Constipation. Some other side effects of Zimigut 200 Tablet have been listed ahead. Usually, these side effects of Zimigut 200 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Zimigut 200 Tablet's effect during pregnancy is Severe and Severe while nursing. In addition, Zimigut 200 Tablet's effects on the liver, heart and kidney are discussed below in the Zimigut 200 Tablet related warnings section.
Other conditions have been mentioned below in the Zimigut 200 Tablet contraindications section.
Besides this, Zimigut 200 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Zimigut 200 Tablet is considered safe while driving, and is addictive.
Zimigut 200 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Zimigut 200 Tablet is used -
Moderate
Mild
Common
Is the use of Zimigut 200 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Zimigut. If you are pregnant, do not take Zimigut without a doctor's advice.
Is the use of Zimigut 200 Tablet safe during breastfeeding?
Zimigut may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Zimigut 200 Tablet on the Kidneys?
Zimigut is completely safe for kidneys.
What is the effect of Zimigut 200 Tablet on the Liver?
Zimigut may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Zimigut 200 Tablet on the Heart?
Zimigut is completely safe for the heart.
Zimigut 200 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Zimigut 200 Tablet unless your doctor advises you to do so -
Is this Zimigut 200 Tablet habit forming or addictive?
Forming a habit of Zimigut 200 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Zimigut 200 Tablet since it will not make you feel sleepy.
Is it safe?
Yes, Zimigut 200 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Zimigut 200 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Zimigut 200 Tablet
You can take Zimigut 200 Tablet with food.
Interaction between Alcohol and Zimigut 200 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Zimigut 200 Tablet with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097